Author Details

Федянин, Михаил Юрьевич

Issue Section Title File
Vol 17, No 3 (2015) Articles Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review)
Vol 19, No 3 (2017) Articles BCD-100 - first russian PD-1 inhibitor PDF
(Rus)
Vol 19, No 3 (2017) Articles Regorafenib: from clinical research to clinical practice PDF
(Rus)
Vol 21, No 3 (2019) Articles Effect of starting dose of regorafenib on overall survival of patients with metastatic colorectal cancer: a systematic review and meta-analysis PDF
(Rus)
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data PDF
(Rus)
Vol 23, No 4 (2021) CLINICAL ONCOLOGY Multicenter prospective observational post-approval study of safety and efficacy of bevacizumab (Avegra®, BIOCAD) in patients with metastatic colorectal cancer in real world practice: APOLLON-11 and SOYUZ-APOLLON PDF
(Rus)
Vol 25, No 1 (2023) CLINICAL ONCOLOGY The possibilities of therapy of patients with metastatic colorectal cancer with BRAF V600E mutation. Clinical cases PDF
(Rus)
Vol 25, No 3 (2023) CLINICAL ONCOLOGY Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors” PDF
(Rus)
Vol 24, No 4 (2022) CLINICAL ONCOLOGY Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study PDF
(Rus)
Vol 26, No 1 (2024) Articles Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment PDF
(Rus)
Vol 26, No 1 (2024) Articles Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies